Loading clinical trials...

Two-session Catheter-directed Sclerotherapy Using Ethanol for Endometrioma | Clinical Trials | Clareo Health

COMPLETEDNANCT06274086

Two-session Catheter-directed Sclerotherapy Using Ethanol for Endometrioma

The goal of this clinical trial is to evaluate the safety and clinical outcomes of two-session catheter-directed sclerotherapy (CDS) with 96% ethanol in patients with endometrioma. The main question i...

Lead sponsor: Asan Medical Center•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

The Therapy of Large Endometrioma

NCT04704115 · Endometrioma, Endometriosis Ovary

RECRUITING

Selective Removal of Endometriotic Lesions Using CUSA Clarity in Ovarian Endometriomas

NCT07215130 · Ovarian Endometrioma, Endometriosis

RECRUITINGNA

Conservative Endometrioma Surgery

NCT04151433 · Endometriosis Ovary, Endometrioma

RECRUITINGNA

Ethanol Sclerotherapy Prior to ART

NCT05962775 · Endometrioma, Infertility, and more

Enrolling By Invitation

PET/MRI for Evaluation of Endometriosis

NCT06377553 · Endometriosis, Endometrioma

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 23, 2024Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment22

Start dateJun 2020

Last updatedFeb 23, 2024

Condition

Sclerotherapy Endometrioma

Locations shown

Asan Medical Center

Seoul

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 23, 2024Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions